SPDR Select Sector Fund - Health Care (XLV)

89.23 +0.83 (+0.939%)

IEX Real-Time Price

May 21, 2019 EST.

NYSE Arca :

Prev Close 88.4

Price Open 88.9

Volume: 11.68M

Avg Volume: 16.08M

Market Cap: 18.61B

P/E Ratio -

52 Wk Range 80.61-96.06





News

3 Gene Therapy Stocks For A Biotech Portfolio (2019-05-20 12:53 SeekingAlpha)

Biotech Pulse The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have struggled since March as the broader healthcare sector ( XLV ) declined following growing momentum amongst the presidential candidates for a universal healthcare plan. This was at a time when the broader ma…

 


Statistics

Shares Outstanding: 208.57M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 3.82

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: 8.53

Return On Equity: 21.71

Profit Margin: N/A

Price History

Beta: 0.92

50-day Moving Avg: 89.86

200-day Moving Avg: 90.03

YTD Change: 5.12

5-day Change: 1.47

1-month Change: 3.79

3-month Change: -2.34

6-month Change: 0.51

1-year Change: 8.85

Revenue Per Share: 0.00

Revenue Per Employee: N/A



Dividend

Dividend Yield: 1.53

EX-Dividend Date: 2019-03-15

Dividend Rate: 1.36


Company Profile

Name: SPDR Select Sector Fund - Health Care

Exchange: NYSE Arca

Industry:

Sector:

Website: http://www.spdrs.com

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.